Sophie Millar
Sophie Millar completed her doctorate studies in vascular and cannabinoid based medicines at the University of Nottingham, and is currently based in Brussels undertaking a Traineeship at the European Parliament Research Services. She is interested in communicating topics broadly related to drug development and health, and has contributed to a number of STEM outreach activities and articles.-
Re-engineering pharmaceutical research for better patient outcomes
A so-called ‘productivity crisis’ has been ascribed to the pharmaceutical research and development industry. Despite increases in investment and funding, this has not corresponded to increases in the approval of novel drugs. Why do so many drugs fail to receive approval, and what other means should we...
-
A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research
Interview with Dr Síle Lane, head of international campaigns and policy at Sense About Science, about Re-engineering pharmaceutical research. Undisclosed clinical trial results are unfortunately common - how does this impact progression in research and treatment? Síle Lane: When results from clinical...